Literature DB >> 7378274

Effects of chrysotile asbestos on mononuclear cells in vitro.

S Kagamimori, M P Scott, D G Brown, R E Edwards, M M Wagner.   

Abstract

Chrysotile asbestos (400 micrograms/ml) was not found to be cytotoxic towards human blood lymphocytes in culture over a 72 h period, although there was indirect evidence of cytoxicity towards plastic adherent mononuclear cells (PAM). There was significant suppression of 3H-thymidine incorporation into cells cultured with phytohaemagglutinin (PHA) in the presence of fibres. It was found even when chrysotile was added 24 h after PHA. No suppression was found for chrysotile-treated PAM-depleted cultures in comparison to control cultures. Antibody-dependent cell-mediated cytotoxicty (ADCC) was inhibited by the presence of chrysotile, and appeared to be due to prevention of contact between antibody-coated target cells and effector cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378274      PMCID: PMC2041545     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  16 in total

1.  In vitro studies on the cytotoxic action of different varieties of asbestos dust on macrophages.

Authors:  J L Kaw; S H Zaidi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-03

2.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

Review 3.  Effects of silica and asbestos on cells in culture.

Authors:  A C Allison
Journal:  Inhaled Part       Date:  1970

4.  Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes.

Authors:  P Davies; A C Allison; J Ackerman; A Butterfield; S Williams
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

5.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

6.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats.

Authors:  I C MacLennan; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

7.  Monocyte enhancement of mitogen-induced lymphocyte proliferation in a human co-culture system.

Authors:  J R Hollister; C E Jarrett
Journal:  Cell Immunol       Date:  1978-12       Impact factor: 4.868

8.  Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.

Authors:  P L Haslam; A Lukoszek; J A Merchant; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

9.  The biological effects of magnesium-leached chrysotile asbestos.

Authors:  A Morgan; P Davies; J C Wagner; G Berry; A Holmes
Journal:  Br J Exp Pathol       Date:  1977-10

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  4 in total

1.  In vitro suppression of fibroblast growth inhibitory lymphokine production by asbestos.

Authors:  I Lemaire; C Dubois
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

2.  Elevated binding activity of CD8+ cells with phytohaemagglutinin by asbestos fibre in vitro.

Authors:  K Kinugawa; F Hyodoh; A Andoh; A Ueki; H Tanaka; Y Mochizuki
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  An immunological study on patients with chronic cadmium disease.

Authors:  W R Williams; S Kagamimori; M Watanabe; T Shinmura; N Hagino
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Asbestos related changes in pulmonary and systemic immune responses--early enhancement followed by inhibition.

Authors:  M Rola-Pleszczynski; I Lemaire; P Sirois; S Massé; R Bégin
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.